Logo image
Lipidomic profiles and their relationship to incident diabetic retinopathy in type 2 diabetes: The Fremantle Diabetes Study Phase II
Journal article   Open access   Peer reviewed

Lipidomic profiles and their relationship to incident diabetic retinopathy in type 2 diabetes: The Fremantle Diabetes Study Phase II

Timothy M.E. Davis, Jocelyn J. Drinkwater, Alanah Grant-St James, Elaine Holmes, Wendy A. Davis and Nicola Gray
Journal of diabetes and its complications, Vol.40(11), 109412
2026
PMID: 42748732
pdf
Published2.03 MBDownloadView
Open Access CC BY V4.0

Abstract

Diabetic retinopathy Incidence Lipid biomarkers Type 2 diabetes Ultra-performance liquid chromatography-tandem mass spectrometry
To determine whether plasma lipid profiles predict diabetic retinopathy (DR). DR status (none, mild non-proliferative diabetic retinopathy (NPDR), moderate NPDR, severe NPDR/worse) was categorised in 762 adults with type 2 diabetes (mean age 64.5 years, 54.3% males) at baseline and Year 4/6. Ultra-performance liquid chromatography-tandem mass spectrometry generated baseline plasma lipid profiles. Multiple logistic regression identified baseline associates of new/worsening DR and incident DR. The likelihood ratio test (LRT) evaluated incremental biomarker contribution. The net reclassification improvement (NRI) was calculated. New/worsening DR occurred in 121 (16%). Of 495 without DR at baseline, 35 (7.0%) developed DR. For new/worsening DR, the inclusion of cholesterol ester (20:4), fatty acid (20:3) and lysophosphatidylglycerol (18:1) in addition to conventional risk factors (hypertension, HbA1c, diabetes treatment intensity, urinary albumin:creatinine) added to the conventional model predictivity (LRT, P = 0.00002). The NRI gain at a 10% cut-off was 5.7% (SE 2.8%; P = 0.043). For incident DR, fatty acid (20:3), lysophosphatidylglycerol (18:0) and phosphatidylcholine (18:0_20:3) with HbA1c improved model performance (LRT, P = 0.00001). The NRI gain at 5% risk cut-off for incident DR was 28.3% (P = 0.002). This exploratory study identified five lipid biomarkers with the potential to improve DR risk prediction and the understanding of pathophysiological mechanisms. •Lipidomic biomarkers could enhance prediction of incident diabetic retinopathy (DR).•Baseline plasma lipid profiles were generated in people living with type 2 diabetes.•New/worsening DR and incident DR were assessed over 4 years of follow-up.•Five lipid moieties added to conventional variables in predicting these outcomes.•Lipid biomarkers may improve DR risk prediction and provide mechanistic insights.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

Metrics

1 Record Views
Logo image